MX2016015326A - Combinacion, composicion y metodo de administracion de la combinacion o composicion a animales. - Google Patents

Combinacion, composicion y metodo de administracion de la combinacion o composicion a animales.

Info

Publication number
MX2016015326A
MX2016015326A MX2016015326A MX2016015326A MX2016015326A MX 2016015326 A MX2016015326 A MX 2016015326A MX 2016015326 A MX2016015326 A MX 2016015326A MX 2016015326 A MX2016015326 A MX 2016015326A MX 2016015326 A MX2016015326 A MX 2016015326A
Authority
MX
Mexico
Prior art keywords
composition
combination
animals
combinations
administering
Prior art date
Application number
MX2016015326A
Other languages
English (en)
Inventor
W Bafundo Kenneth
Bruce Johnson A
CALABOTTA David
Knehans Wendell
Original Assignee
Phibro Animal Health Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phibro Animal Health Corporation filed Critical Phibro Animal Health Corporation
Publication of MX2016015326A publication Critical patent/MX2016015326A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/012—Coccidia antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Birds (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

En el presente documento se desvelan realizaciones de una combinación y/o composición para administración a animales. En algunas realizaciones, la combinación y/o composición puede administrarse para tratar y/o prevenir una enfermedad en animales. En algunas realizaciones, la combinación y/o composición puede administrarse para promover la salud del animal. En algunas realizaciones, la combinación comprende una composición que comprende Yucca schidigera, Quillaja saponaria, y combinaciones de las mismas, y una composición que comprende un antimicrobiano, un antibiótico, un anticoccidial, una vacuna, o combinaciones de los mismos. Las combinaciones o composiciones desveladas en el presente documento también pueden mejorar los índices de conversión de alimento en animales.
MX2016015326A 2014-05-23 2015-05-22 Combinacion, composicion y metodo de administracion de la combinacion o composicion a animales. MX2016015326A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462002527P 2014-05-23 2014-05-23
PCT/US2015/032301 WO2015179840A1 (en) 2014-05-23 2015-05-22 Combination, composition, and method of administering the combination or composition to animals

Publications (1)

Publication Number Publication Date
MX2016015326A true MX2016015326A (es) 2017-05-30

Family

ID=53366304

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016015326A MX2016015326A (es) 2014-05-23 2015-05-22 Combinacion, composicion y metodo de administracion de la combinacion o composicion a animales.

Country Status (18)

Country Link
US (3) US10413581B2 (es)
EP (1) EP3145522B1 (es)
JP (2) JP6869177B2 (es)
KR (1) KR20170008850A (es)
CN (1) CN106659787A (es)
AU (2) AU2015263877B2 (es)
BR (1) BR112016027335B1 (es)
CA (1) CA2949965A1 (es)
CL (1) CL2016002992A1 (es)
ES (1) ES2856207T3 (es)
IL (1) IL249061B (es)
MX (1) MX2016015326A (es)
MY (1) MY181854A (es)
PH (1) PH12016502323A1 (es)
PL (1) PL3145522T3 (es)
RU (1) RU2707076C2 (es)
WO (1) WO2015179840A1 (es)
ZA (1) ZA201608077B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6045895B2 (ja) 2012-10-01 2016-12-14 株式会社トプコン 眼科観察装置
US11238056B2 (en) 2013-10-28 2022-02-01 Microsoft Technology Licensing, Llc Enhancing search results with social labels
US11645289B2 (en) 2014-02-04 2023-05-09 Microsoft Technology Licensing, Llc Ranking enterprise graph queries
WO2015123456A1 (en) 2014-02-12 2015-08-20 OmniGen Research, L.L.C. Composition and method for promoting reduction of heat stress in animals
US9870432B2 (en) 2014-02-24 2018-01-16 Microsoft Technology Licensing, Llc Persisted enterprise graph queries
US11657060B2 (en) 2014-02-27 2023-05-23 Microsoft Technology Licensing, Llc Utilizing interactivity signals to generate relationships and promote content
US10757201B2 (en) 2014-03-01 2020-08-25 Microsoft Technology Licensing, Llc Document and content feed
US10169457B2 (en) 2014-03-03 2019-01-01 Microsoft Technology Licensing, Llc Displaying and posting aggregated social activity on a piece of enterprise content
US10394827B2 (en) 2014-03-03 2019-08-27 Microsoft Technology Licensing, Llc Discovering enterprise content based on implicit and explicit signals
US10255563B2 (en) 2014-03-03 2019-04-09 Microsoft Technology Licensing, Llc Aggregating enterprise graph content around user-generated topics
WO2015179840A1 (en) * 2014-05-23 2015-11-26 Phibro Animal Health Corporation Combination, composition, and method of administering the combination or composition to animals
US10061826B2 (en) * 2014-09-05 2018-08-28 Microsoft Technology Licensing, Llc. Distant content discovery
WO2017044832A1 (en) 2015-09-09 2017-03-16 Omnigen Research, Llc A composition and/or combination for aquaculture
NO345485B1 (en) 2016-07-29 2021-03-01 Saponin Res Center S A Use of Quillaja saponaria extracts for the prevention and control of bacterial infections in fish and compositions comprising such extracts
CA2972174C (en) 2016-07-29 2022-01-11 Saponin Research Center S.A. Use of quillaja saponaria extracts for the prevention and control of viral infections in fish
MA48942A (fr) 2017-05-22 2020-04-08 Hoffmann La Roche Composés thérapeutiques, compositions et procédés d'utilisation associés
CN107535727A (zh) * 2017-10-29 2018-01-05 镇江龙润生态农业发展有限公司 一种含有中草药的用于肉鸡无抗生态养殖的饲料添加剂
CN112087953A (zh) * 2018-01-24 2020-12-15 奥姆尼根研究有限责任公司 给动物施用的芽孢杆菌组合
CN108553640A (zh) * 2018-06-13 2018-09-21 佛山市正典生物技术有限公司 一种鸡球虫病弱毒活疫苗及其制备方法和应用
AU2021291285A1 (en) * 2020-06-19 2023-02-09 Kimberly-Clark Worldwide, Inc. Animal feed composition for reducing ammonia production
BR112022025821A2 (pt) * 2020-06-19 2023-01-10 Kimberly Clark Co Uso de um extrato de uma planta não lenhosa do gênero hesperaloe , uso de uma composição compreendendo pelo menos uma saponina extraída de uma planta não lenhosa do gênero hesperaloe, uso de imunomodulador derivado de hesperaloe, e, composição imunogênica
US20220030913A1 (en) * 2020-08-03 2022-02-03 Hoxie Feedyard, LLC Supplement for livestock
CN116194090A (zh) * 2020-09-25 2023-05-30 Cj第一制糖株式会社 包含芪类化合物的抗球虫组合物及其用途
US20240148671A1 (en) * 2021-03-10 2024-05-09 Cornell University Methods for improving poultry health
CN113057141A (zh) * 2021-05-10 2021-07-02 天津农学院 一种提高蛋鸡蛋黄中卵磷脂含量的饲喂方法
ES2932416B2 (es) * 2021-07-07 2023-09-28 Biovet S A Aditivo para animales que contiene saponinas, compuestos fenolicos y p-cimenol, y procedimiento para su obtencion
WO2023163884A1 (en) * 2022-02-22 2023-08-31 Phibro Animal Health Corporation Liquid formulation comprising yucca and quillaja for administration to animals
WO2024156767A1 (en) * 2023-01-25 2024-08-02 Nutreco Nederland B.V. Method of feeding (pre)ruminants

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07107923A (ja) 1993-10-13 1995-04-25 Taiyo Kagaku Co Ltd 飼料用組成物
JP3422834B2 (ja) * 1994-02-09 2003-06-30 日本農産工業株式会社 飼料添加剤
JP3623994B2 (ja) 1994-11-05 2005-02-23 太陽化学株式会社 甲殻類の感染症抑制飼料組成物
CA2197751A1 (en) 1996-02-26 1997-08-27 F. Hoffmann-La Roche Ag Growth promotion in chickens
TWI223595B (en) 1999-09-07 2004-11-11 Distributors Proc Inc Steroidal sapogenins for the control of coccidiosis in animals
ES2288550T3 (es) 2001-01-08 2008-01-16 Pathway Intermediates Limited Compuestos autoinductores y sus utilizaciones.
US20040096527A1 (en) * 2001-02-27 2004-05-20 Jin-Hyuck Jang Compositions for lowering serum cholesterol level
ZA200400479B (en) * 2001-07-06 2006-05-31 Abic Biolog Lab Teva Nucleic acids encoding recombinant 56 a 82 KDA antigens from gametocytes of Eimeria maxima and their use
JP3995541B2 (ja) * 2002-06-28 2007-10-24 株式会社ゲン・コーポレーション 抗鶏コクシジウム症組成物
WO2004007525A2 (en) * 2002-07-10 2004-01-22 Akzo Nobel N. V. Immunogenic composition comprising a fusion protein and a saponin adjuvant
US7416742B2 (en) * 2004-06-16 2008-08-26 Sartec Corporation Methods and compositions for controlling microorganism populations in the digestive system of animals
CN101563090B (zh) * 2006-11-20 2013-01-02 杜科姆公司 包含南美皂皮树皂苷的含脂质颗粒用于治疗癌症的用途
TW201010719A (en) * 2008-08-19 2010-03-16 Wyeth Corp Immunological composition
US20100150958A1 (en) * 2008-12-15 2010-06-17 Vectogen Pty Ltd. Methods and Compositions for Use of a Coccidiosis Vaccine
ES2386474B1 (es) 2011-01-21 2013-07-09 Norel, Sa Aditivos para alimentación animal.
WO2015179840A1 (en) * 2014-05-23 2015-11-26 Phibro Animal Health Corporation Combination, composition, and method of administering the combination or composition to animals
CN112087953A (zh) * 2018-01-24 2020-12-15 奥姆尼根研究有限责任公司 给动物施用的芽孢杆菌组合

Also Published As

Publication number Publication date
EP3145522B1 (en) 2020-12-23
ES2856207T3 (es) 2021-09-27
AU2015263877A1 (en) 2017-01-12
KR20170008850A (ko) 2017-01-24
RU2707076C2 (ru) 2019-11-22
CA2949965A1 (en) 2015-11-26
IL249061A0 (en) 2017-01-31
CN106659787A (zh) 2017-05-10
US20190350998A1 (en) 2019-11-21
US10912810B2 (en) 2021-02-09
JP2020090502A (ja) 2020-06-11
IL249061B (en) 2020-05-31
PL3145522T3 (pl) 2021-06-14
US10413581B2 (en) 2019-09-17
PH12016502323A1 (en) 2017-02-06
JP6869177B2 (ja) 2021-05-12
AU2021202307B2 (en) 2022-06-30
BR112016027335B1 (pt) 2021-06-08
RU2016149801A3 (es) 2018-11-14
MY181854A (en) 2021-01-11
US20210113647A1 (en) 2021-04-22
CL2016002992A1 (es) 2017-05-19
ZA201608077B (en) 2020-01-29
JP2017517570A (ja) 2017-06-29
AU2021202307A1 (en) 2021-05-13
EP3145522A1 (en) 2017-03-29
WO2015179840A1 (en) 2015-11-26
RU2016149801A (ru) 2018-06-25
US20170072002A1 (en) 2017-03-16
AU2015263877B2 (en) 2021-01-21

Similar Documents

Publication Publication Date Title
PH12016502323A1 (en) Combination, composition, and method of administering the combination or composition to animals
PH12018500499A1 (en) A composition and/or combination for aquaculture
MX2015016155A (es) Formulaciones en gel para dirigir la radioterapia.
MY188139A (en) Sodium channel modulators for the treatment of pain
MX2017005721A (es) Composicion veterinaria masticable agradable al paladar.
PH12017500708A1 (en) Probiotic and prebiotic compositions
MX2017002816A (es) Derivados de pirazolopiridina y su uso en terapia.
HK1217897A1 (zh) 通過干擾素的經皮和/或經粘膜給藥治療骨癌、皮膚癌、皮下癌、粘膜癌和/或粘膜下癌的方法和組合物
MX2022009155A (es) Nuevos profarmacos polimericos de la hormona del crecimiento humana (hgh).
BR112018009264A2 (pt) composições para cuidados de animais de estimação
PH12016502352A1 (en) Pharmaceutical composition
TW201613578A (en) Pharmaceutical combinations
MX2016007316A (es) Prevencion de infecciones por staphylococcus aureus mediante vacunas de glucoproteina sintetizadas en escherichia coli.
PH12019501439A1 (en) Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus
PH12019502241A1 (en) Berberine alkaloids in the prevention and/or treatments of intestinal disease
UA118474C2 (uk) (s)-пірліндол та його фармацевтично прийнятні солі для застосування в медицині
MX2018000262A (es) Usos terapeuticos de formulaciones de berberina.
MX2018014129A (es) Composiciones farmaceuticas de oligomero de morfolino fosforodiamidato.
MX2016005092A (es) Composiciones farmaceuticas de estradiol insertadas en la vagina y metodos.
MX2022014763A (es) Composiciones de grapiprant y metodos para usar las mismas.
UA117751C2 (uk) Похідні тилозину і спосіб їх одержання
MX2016014701A (es) (r)-pirlindol y sus sales farmaceuticamente aceptables para uso en medicina.
GB2550750A (en) Anthelmintic compounds
MX2016004961A (es) Procedimientos y composiciones para el tratamiento de infecciones por s. equi.
EP3435782A4 (en) METHOD AND COMPOSITIONS FOR REDUCING ANTIBIOTIC ACID DELIVERY TO UTILIZED ANIMALS